IRF5 antibody
Principal name
IRF5 antibody
Alternative names for IRF5 antibody
Interferon regulatory factor 5, IRF-5
Ncbi ID
NP_001092097.2, 9606, NP_116032, NP_036187, NP_116032.1, NP_002191, NM_032643, NM_001098627, NP_001092099, NP_001092097, NP_001092100, NP_002191.1, NP_036187.1, NM_012057, NM_002200, NM_001098631, NM_001098628
Available reactivities
Available hosts
Available applications
Immunocytochemistry/Immunofluorescence (ICC/IF), Flow Cytometry (F), Enzyme Immunoassay (E), Immunoprecipitation (IP), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection)), ChIP assay (ChIP)
Background of IRF5 antibody
Interferon regulatory factors (IRFs) comprise a family of transcription factors that function within the Jak/Stat pathway to regulate interferon (IFN) and IFN-inducible gene expression in response to viral infection. IRFs play an important role in pathogen defense, autoimmunity, lymphocyte development, cell growth, and susceptibility to transformation. The IRF family includes nine members: IRF-1, IRF-2, ISGF3?/p48, IRF-3, IRF-4 (Pip/LSIRF/ICSAT), IRF-5, IRF-6, IRF-7, and IRF-8/ICSBP. All IRF proteins share homology in their amino-termil D-binding domains. IRF family members regulate transcription through interactions with proteins that share similar D-binding motifs, such as IFN-stimulated response elements (ISRE), IFN consensus sequences (ICS), and IFN regulatory elements (IRF-E). IRF-5 is expressed in lymphoid tissues and peripheral blood lymphocytes and participates in the induction of type I interferon genes following viral infection. Activation of IRF-5 sigling is triggered by the toll-like receptor (TLR) pathway, including TLR7 and MyD88. Genetic variants of IRF-5 have been associated with disorders where the IFN pathway is abnormally activated, such as systemic lupus erythematosus .
General readings
Barnes B.J., et al (2001). J. Biol. Chem. 276:23382-23390
Schoenemeyer A., et al (2005). J. Biol. Chem. 280:17005-17012































- Quick-Filters:
- Highly Validated (3)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA507252 | IRF5 antibody |
||||||
| IRF5 mouse monoclonal antibody, clone OTI1G7 (formerly 1G7) | |||||||
![]() |
Mouse | IgG1 | OTI1G7 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
+6 additional images |
Highly validated antibody! |
||||||
| SM6008 | IRF5 (176-240) antibody |
||||||
![]() |
Mouse | IgG1 | 10T1 | Purified | Hu, Ms | E, F, ICC/IF, IP, P, WB |
0.1 ml /
€330.00
|
| OriGene Technologies GmbH | |||||||
+3 additional images |
Highly validated antibody! |
||||||
| SM6008S | IRF5 (176-240) antibody |
||||||
![]() |
Mouse | IgG1 | 10T1 | Purified | Hu, Ms | E, F, ICC/IF, IP, P, WB |
50 µl /
€220.00
|
| OriGene Technologies GmbH | |||||||
+3 additional images |
Highly validated antibody! |
||||||
| TA302667 | IRF5 (C-term) antibody |
||||||
| Goat Polyclonal Antibody against IRF5 | |||||||
![]() |
Goat | Aff - Purified | Bov, Hu, Ms, Rt | ChIP, E, IP, P, WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| TA312432 | IRF5 antibody |
||||||
| Rabbit polyclonal anti-IRF5 antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA324738 | IRF5 (N-term) antibody |
||||||
| Rabbit polyclonal IRF5 Antibody (N-term) | |||||||
![]() |
Rabbit | Ig | Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
+2 additional images |
|||||||
| TA326952 | IRF5 antibody |
||||||
| IRF5 Rabbit Polyclonal Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt |
0.1 mg /
€335.00
|
||
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| TA507246 | IRF5 antibody |
||||||
| IRF5 mouse monoclonal antibody, clone OTI1A5 (formerly 1A5) | |||||||
![]() |
Mouse | IgG2a | OTI1A5 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| TA507251 | IRF5 antibody |
||||||
| IRF5 mouse monoclonal antibody, clone OTI1B8 (formerly 1B8) | |||||||
![]() |
Mouse | IgG1 | OTI1B8 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN200458 | IRF5 - human gene knockout kit via CRISPR |
||
![]() |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN200458BN | IRF5 - human gene knockout kit via CRISPR |
||
![]() |
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN200458LP | IRF5 - human gene knockout kit via CRISPR |
||
![]() |
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN200458RB | IRF5 - human gene knockout kit via CRISPR |
||
![]() |
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN308427 | Irf5 - mouse gene knockout kit via CRISPR |
||
![]() |
Mouse | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN308427BN | Irf5 - mouse gene knockout kit via CRISPR |
||
![]() |
Mouse | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN308427LP | Irf5 - mouse gene knockout kit via CRISPR |
||
![]() |
Mouse | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN308427RB | Irf5 - mouse gene knockout kit via CRISPR |
||
![]() |
Mouse | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP300458 | IRF5 (transcript variant 2) |
||||
| Recombinant protein of human interferon regulatory factor 5 (IRF5), transcript variant 2 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP311941 | IRF5 (transcript variant 5) |
||||
| Recombinant protein of human interferon regulatory factor 5 (IRF5), transcript variant 5 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP315434 | IRF5 (transcript variant 3) |
||||
| Recombinant protein of human interferon regulatory factor 5 (IRF5), transcript variant 3 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||















+6 additional images










